Amoxicillin was ineffective for treating LRTI (lower respiratory tract infections) in children, according to research published in the Lancet.
The double-blind trial included 432 children (median age, 3.2 years; 46% female) who presented to primary care in England with acute uncomplicated lower respiratory tract infections.
Patients in the study had symptoms for less than 21 days. The study investigators randomly assigned patients to receive either 50 mg/kg/day amoxicillin (n=221) or placebo oral suspension (n=211) for 7 days.
During the treatment period, the researchers evaluated the duration of symptoms rated moderately bad or worse for up to 28 days or until resolution of symptoms occurred. Symptoms were assessed with a validated diary.
Get the full story at pulmonologyadvisor.com.
Amoxicillin ineffective LRTI
Go To Source For Respiratory Therapy Coverage
RT delivers in-depth coverage of the clinical, regulatory, and technology landscape for respiratory therapy—and reaches more than 28,000 key decision-makers and influencers. As one of healthcare’s most important data companies, we facilitate the rapid adoption of medical devices and practice management tools into the industry.
Go To Source For Respiratory Therapy Coverage RT delivers in-depth coverage of the clinical, regulatory, and technology landscape for respiratory therapy—and reaches more than 28,000 key decision-makers and influencers. As one of healthcare’s most important data companies, we facilitate the rapid adoption of medical devices and practice management tools into the industry. Go To Source For Respiratory Therapy Coverage RT delivers in-depth coverage of the clinical, regulatory, and technology landscape for respiratory therapy—and reaches more than 28,000 key decision-makers and influencers. As one of healthcare’s most important data companies, we facilitate the rapid adoption of medical devices and practice management tools into the industry.
